Background {#Sec1}
==========

Studies in litter-bearing mammals have found that hormones can transfer from one fetus to adjacent fetuses in the uterus \[[@CR1]\]. Fetuses located between two males have increased concentrations of testosterone compared to fetuses located between two females \[[@CR2]\], and such fetuses are heavier, suggesting that the intrauterine position may influence metabolic set points involved in the regulation of body weight and fat storage \[[@CR3]\].

Whether an analogous effect exists in humans is uncertain; however, it has been postulated that twins influence each other hormonally during prenatal life because they share their intrauterine environment \[[@CR4]\]. This is called the twin testosterone transfer (TTT) hypothesis. In particular, females who develop with a male co-twin are potentially exposed to higher levels of prenatal testosterone, the most potent androgen, than females from same-sex (SS) twin pairs \[[@CR5]\]. Support for the TTT hypothesis comes from previous twin studies showing that females from opposite-sex (OS) twin pairs express more male-typical characteristics (i.e., are masculinized) in a variety of sexually dimorphic traits. One phenotype with a replicated finding of masculinization of females with a male co-twin is the Mental Rotation Test, which measures a specific cognitive ability with a large sex difference favoring males \[[@CR6], [@CR7]\]. However, also postnatal socialization effects need to be considered as an alternative explanation to the TTT hypothesis. Having grown up with a sibling of the same sex versus a sibling of the opposite sex is likely to result in different social learning experiences and has been linked to sex-typed behavior; for example, boys with older brothers and girls with older sisters have been found to be more sex typed than children from opposite-sex sibling dyads \[[@CR8]\].

Among the few studies that have specifically compared anthropometric and health-related variables, some differences between females from OS and SS twin pairs have been reported, for example, for height \[[@CR9]\], birth weight \[[@CR10]\], body mass index (BMI) \[[@CR11]\], dyslipidemia \[[@CR11]\], and leukocyte telomere lengths \[[@CR12]\]. However, it is important to note that null reports also exist for several traits. For example, there are no differences between OS and SS female twins with regard to the prevalence of polycystic ovary syndrome \[[@CR13]\] or hormone-related cancers \[[@CR14]\]. Similarly, males from SS twin pairs could be masculinized compared with OS males due to additional testosterone exposure of the male co-twin, although most studies that have investigated co-twin effects in males have failed to identify differences between OS and SS male twins \[[@CR5], [@CR15]\].

Many previous studies are constrained by several limiting factors, including small sample size, lack of replication, and the inclusion of monozygotic (MZ) twins in the SS groups, which is questionable due to the variation in placentation patterns between MZ and dizygotic (DZ) twin pairs \[[@CR5]\]. Furthermore, publication bias is likely to have occurred, with non-significant results being less likely to be published than significant ones \[[@CR16]\]. In 2011, Tapp et al. reviewed the evidence that fetuses gestated with a male co-twin are masculinized during the development due to prenatal androgen exposure and concluded that while accumulated evidence lacks consistency, it is sufficient to warrant further research, ideally using large samples of OS and SS twin pairs \[[@CR15]\].

To this end, the present study aims to test whether two sexually dimorphic anthropometric traits, height and BMI and the prevalence of overweight and obesity differ between females and males from OS and SS DZ twin pairs. Consistent with the TTT hypothesis, OS females are predicted to be taller and have a higher BMI than SS females, and SS males are predicted to be taller and have a higher BMI than OS males. The sample was drawn from the newly established CODATwins (Collaborative project of Development of Anthropometrical measures in Twins) database \[[@CR17]\], which, being based on original data, avoids publication bias and is very large and able to address the hypothesis with much greater power than previous studies.

Methods {#Sec2}
=======

Sample {#Sec3}
------

The CODATwins project is a major international twin collaboration that was initiated in 2013 to pool data on zygosity, weight, and height from twin cohorts across the world. A description of the project and the participating twin cohorts was reported previously in detail \[[@CR17]\]. The main CODATwins database includes 960,859 height and weight measures from both MZ and DZ twins. Extreme outliers and biologically implausible values for height and BMI were inspected visually for each age decade and by sex, resulting in elimination of less than 0.2% of the observations from the original database. For the present study, we excluded (1) all measurements prior to the age of 20 years to avoid confounding by pubertal stage; (2) MZ twins (*n* = 165,305); (3) DZ twin individuals with missing information on OS or SS status; (4) cohorts which did not collect data from OS twins; and (5) cohorts for which only a few OS twins were available, i.e., if the ratio of OS to SS DZ twins was \<0.15 (the expectation being unity as sex is determined independently in the two fetuses). As a sensitivity analysis, excluding eight cohorts with 2866 twins with a ratio below 0.6 rather than 0.15 did not change the results (data available on request). Furthermore, if there were multiple observations for an individual, we restricted the analyses to one observation per individual by using the observation at the youngest age. The effect sizes were virtually unchanged when using older observations as opposed to younger observations, and therefore, only the latter results are presented. In total, 31 cohorts from 19 countries met our inclusion criteria (Additional file [1](#MOESM1){ref-type="media"}: Tables S1 and S2). The final sample for the present analysis consisted of 122,302 DZ twin individuals of which 68,494 were from SS and 53,808 from OS twin pairs. The median age (and interquartile range) of the participants was 44.0 (28.7--56) years for males and 42.0 (28.0--55.9) years for females (Additional file [1](#MOESM1){ref-type="media"}: Table S1 for females and Additional file [1](#MOESM1){ref-type="media"}: Table S2 for males show these descriptive statistics by twin type and cohort). In order to examine age effects, the sample was divided into younger (\<50 years) and older (50+ years) age groups, which is a proxy for menopausal status in women. Among the 66,956 females and 55,346 males, 63 and 62%, respectively, were classified as younger adults. Height and weight were almost all self-reported (97%). BMI calculated as body weight in kilograms divided by height in meters squared (kg/m^2^) was used as an indicator of adiposity. Zygosity was determined by questionnaires or DNA genotyping depending on the study \[[@CR17]\].

Statistical analysis {#Sec4}
--------------------

The statistical analyses were performed using Stata (version 13.0, Stata Corporation, TX, USA) where *p* \< 0.05 was considered statistically significant. Descriptive statistics for the OS and SS twins are reported as means and standard deviations (SD) separately for females and males. Multiple regression analysis with the twin type (i.e., opposite versus same sex) as a predictor was carried out to compare height and BMI in twins from OS pairs with those from SS pairs. Regression coefficients are shown with their 95% confidence intervals (CIs). Marginal means, i.e., adjusted for cohort, age, and birth year, are presented by twin type along with CIs. Logistic regression models adjusted for cohort, age, and birth year were used to calculate the adjusted odds ratios (OR) and 95% CIs for being overweight or obese with the twin type as a predictor. WHO Asian BMI cut-off points (overweight ≥23 kg/m^2^ and obese ≥27.5 kg/m^2^) were used for Asian cohorts, and WHO standard BMI cut-off points (overweight ≥25 kg/m^2^ and obese ≥30 kg/m^2^) were applied for all other cohorts (from Europe, North-America, and Australia) \[[@CR18]\]. In all regression models, SS twins were set as the reference group. The non-independence (clustering) within twin pairs was taken into account in both multiple and logistic regression analyses by using the "cluster" option in Stata to yield robust estimators of variance \[[@CR19]\].

To assess heterogeneity across cohorts, a random-effects meta-analysis with inverse variance weighting derived from the DerSimonian and Laird estimator was performed using the user-written "metan" command in Stata and visualization of forest plots. The *I* ^2^ statistic was used to examine variability in effect sizes between cohorts. The *I* ^2^ statistic estimates the proportion of variation in effect sizes due to heterogeneity, whereby values of 25--49, 50--74, and \>75% indicate low, moderate, and high heterogeneity, respectively \[[@CR20]\].

Results {#Sec5}
=======

Males were taller (mean ± SD 178.42 ± 7.24 versus 164.80 ± 6.78 cm, *p* \< 0.001) and had a higher BMI (mean ± SD 25.23 ± 3.63 versus 23.97 ± 4.50 kg/m^2^, *p* \< 0.001) than females. Descriptive statistics for age, height, and BMI are shown for the OS and SS female and male twins in Table [1](#Tab1){ref-type="table"}. Both men and women were on average tallest in the Netherlands and shortest in Sri Lanka. Mean BMI was lowest for women from South Korea and men from Japan and highest for African American men and women (Additional file [1](#MOESM1){ref-type="media"}: Tables S1 and S2).Table 1Age and unadjusted height (cm) and BMI (kg/m^2^) in females and males from same- and opposite-sex twin pairsFemalesMalesSSOSSSOSNumber of individuals39,85627,10028,63826,708Age Mean43.943.044.543.3 SD16.915.716.615.6 Min20.020.020.020.0 Max99.095.999.294.5Height Mean164.6165.0178.3178.5 SD6.86.77.27.2 Min135.0135.7147.0145.0 Max193.0194.0208.3207.0BMI Mean24.024.025.225.3 SD4.64.43.63.7 Min13.113.314.213.4 Max49.949.847.849.8*SS* same sex, *OS* opposite sex, *SD* standard deviation, *Min* minimum, *Max* maximum, *BMI* body mass index

Female twins with a male co-twin were on average 0.31 cm taller than females with a female co-twin (*p* \< 0.0001). Male twins with a female co-twin were 0.14 cm taller than male twins with a male co-twin (*p* = 0.025) (Table [2](#Tab2){ref-type="table"}). There were no significant differences in BMI between OS and SS females or between OS and SS males (Table [2](#Tab2){ref-type="table"}). The estimates did not differ between the younger (*β* = −0.04 kg/m^2^, 95% CI −0.13, 0.05 for females and *β* = −0.01 kg/m^2^, 95% CI −0.09, 0.07 for males) or older groups (*β* = −0.05 kg/m^2^, 95% CI −0.07, 0.16 for females and *β* = −0.06 kg/m^2^, 95% CI −0.03, 0.16 for males) separately.Table 2Adjusted means and regression coefficient for height (cm) and BMI (kg/m^2^) in females and males from same- and opposite-sex twin pairsPhenotypeTwin typeMean95% confidence intervalsRegression coefficient95% confidence intervalsHeightSS females164.7164.6, 164.8OS females165.0164.9, 165.10.31 cm0.20, 0.41SS males178.4178.3, 178.4OS males178.5178.4, 178.60.14 cm0.02, 0.27BMISS females23.9523.90, 24.00OS females24.0023.05, 24.050.05 kg/m^2^−0.02, 0.12SS males25.2025.16, 25.25OS males25.2625.22, 25.310.06 kg/m^2^0.00, 0.12The results are adjusted for cohort, age and birth year, and the non-independence (clustering) of observations within twin pairs*SS* same sex, *OS* opposite sex, *BMI* body mass index

The ORs for overweight and obesity did not differ between OS and SS females nor between OS and SS males (Table [3](#Tab3){ref-type="table"}). When analysed by age group, the ORs for overweight did not differ from 1.00 for the younger (OR = 0.99, 95% CI 0.94, 1.03 for females and OR = 0.99, 95% CI 0.95, 1.04 for males) or older group (OR = 1.05, 95% CI 0.99, 1.11 for females and OR = 1.02, 95% CI 0.96, 1.08 for males). Females from OS twin pairs were at a reduced risk of obesity (OR = 0.90, 95% CI 0.83, 0.97) in the younger but not in the older age group (OR = 0.98, 95% CI 0.90, 1.07), but the 95% CIs for these two estimates were overlapping. For males, there was no difference in obesity risk in either age group (OR = 1.04, 95% CI 0.96, 1.13 in the younger and OR = 1.04, 95% CI 0.95, 1.14 in the older group).Table 3Prevalence and adjusted odds ratios for overweight and obesity in females and males from same- and opposite-sex twin pairsPhenotypeTwin type% overweight/obese95% confidence intervalsOdds ratio95% confidence intervalsOverweightSS females30.229.7, 30.71.00 (reference)OS females30.930.3, 31.41.030.99, 1.07SS males47.046.4, 47.71.00 (reference)OS males47.647.0, 48.21.020.99, 1.06ObesitySS females8.458.15, 8.761.00 (reference)OS females8.117.78, 8.440.960.90, 1.01SS males8.047.70, 8.341.00 (reference)OS males8.488.13, 8.831.061.00, 1.13The results are adjusted for cohort, age and birth year, and the non-independence (clustering) of observations within twin pairs. Overweight was defined as ≥23 kg/m^2^ and obesity as ≥27.5 kg/m^2^ for Asian cohorts and as BMI ≥25 kg/m^2^ and BMI ≥30 kg/m^2^, respectively, for all other cohorts*SS* same sex, *OS* opposite sex

The random effect meta-analysis found low to moderate heterogeneity between cohorts, with *I* ^2^ ranging from 32 to 56%. The pooled regression coefficients for height were *β* = 0.31 cm (95% CI 0.10, 0.53) and *β* = 0.18 cm (95% CI −0.03, 0.40) in females and males, respectively (Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}). For BMI, the corresponding values were *β* = 0.02 kg/m^2^ (95% CI −0.09, 0.14) and *β* = 0.04 kg/m^2^ (95% CI −0.06, 0.13) for females and males, respectively (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}).Fig. 1Regression coefficient and 95% CIs using a random-effects model with height as the dependent variable and twin type as the independent variable for females. The effect size shows the increase in height of OS females as compared to dizygotic SS females. If the twin testosterone hypothesis were supported, the effect would be in the positive direction, and the effect size would be significant. The results are adjusted for age and birth year and the non-independence (clustering) of observations within twin pairs. *Squares* indicate study-specific regression coefficients, and the size of the *squares* is proportional to the weight of each study, i.e., the inverse of the variance. The *horizontal lines* represent 95% CIs Fig. 2Regression coefficient and 95% CIs using a random-effects model with height as the dependent variable and twin type as the independent variable for males. The effect size shows the increase in height of OS males as compared to dizygotic SS males. If the twin testosterone hypothesis were supported, the effect would be in the negative direction, and the effect size would be significant. The results are adjusted for age and birth year and the non-independence (clustering) of observations within twin pairs. *Squares* indicate study-specific regression coefficients, and the size of the *squares* is proportional to the weight of each study, i.e., the inverse of the variance. The *horizontal lines* represent 95% CIs Fig. 3Regression coefficient and 95% CIs using a random-effects model with BMI as the dependent variable and twin type as the independent variable for females. The effect size shows the increase in BMI of OS females as compared to dizygotic SS females. If the twin testosterone hypothesis were supported, the effect would be in the positive direction and the effect size would be significant. The results are adjusted for age and birth year and the non-independence (clustering) of observations within twin pairs. *Squares* indicate study-specific regression coefficients, and the size of the *squares* is proportional to the weight of each study, i.e., the inverse of the variance. The horizontal lines represent 95% CIs Fig. 4Regression coefficient and 95% CIs using a random-effects model with BMI as the dependent variable and twin type as the independent variable for males. The effect size shows the increase in BMI of OS males as compared to dizygotic SS males. If the twin testosterone hypothesis were supported, the effect would be in the negative direction and the effect size would be significant. The results are adjusted for age and birth year and the non-independence (clustering) of observations within twin pairs. *Squares* indicate study-specific regression coefficients, and the size of the *squares* is proportional to the weight of each study, i.e., the inverse of the variance. The *horizontal lines* represent 95% CIs

The height differences between OS and SS twins were not associated with the mean heights of the cohorts, showing that height differences between OS and SS twins were not greater in taller cohorts (Additional file [2](#MOESM2){ref-type="media"}: Figure S1). The BMI differences between OS and SS twins were not associated with the mean BMIs of the cohorts for males, but there was an inverse association for females, showing that OS twins tended to have a lower BMI than SS twins with an increasing mean BMI of the cohorts (Additional file [2](#MOESM2){ref-type="media"}: Figure S2). The Spearman correlations were not significant with the exception of BMI for females. Overall, no consistent pattern was observed.

Discussion {#Sec6}
==========

Using this newly established large-scale international twin collaboration, we tested the TTT hypothesis and its possible long-lasting influence on adult height and BMI and find little evidence in support of the hypothesis.

There were no differences in mean BMI or the prevalence of overweight or obesity between twins with a co-twin of the opposite sex and twins with a co-twin of the same sex. Consistent with the TTT hypothesis, we observed that females with a male co-twin were taller than females with a female co-twin. However, we also observed that males with a female co-twin were slightly taller than males with a male co-twin, a finding that is opposite in direction to that predicted by the TTT hypothesis. Yet, our finding for males is in accordance with previous observations on birth weight in twins. Males from OS twin pairs have higher growth rates starting from week 32 of gestation \[[@CR21]\] and a higher mean birth weight when compared with males from SS pairs \[[@CR21], [@CR22]\]. The increased birth weight of males with a female co-twin as compared to males with a male co-twin has been ascribed to the longer duration of gestation of male-female pairs \[[@CR22]\] and the more successful in utero competition for nutrients of males in the presence of a female, rather than a male, co-twin \[[@CR23]\]. Birth weight is an established determinant of adult height \[[@CR24]\], and thus, differences in fetal growth and duration of gestation that depend on the co-twin's sex could also contribute to the small height differences observed in the present analyses.

Furthermore, explanations other than the in utero environment need to be considered. First, postnatal socialization effects could also contribute to differences in anthropometric traits between OS and SS twins, since growing up with a sibling of the same or opposite sex is likely to be different through sibling and parental interactions. However, in previous studies of non-twin siblings, height in childhood was unrelated to the sex of the sibling \[[@CR25]\]. Second, because DZ twins are slightly taller and heavier than MZ twins \[[@CR26]\], misclassification of a small fraction of MZ twins as SS DZ twins could have contributed to part of the observed small differences between twin-type groups. The misclassification rate of questionnaire-based zygosity falls below 5% when compared with genetic markers \[[@CR27]\].

Support for the theory that prenatal exposure to hormones has long-lasting effects on physiology and behavior in later life comes mainly from animal models, in which prenatal androgen exposure has been examined by injecting the developing fetuses with varying doses of testosterone \[[@CR28]--[@CR32]\]. These animal studies have provided evidence that prenatal androgen exposure during the organizational period induces long-term alterations in metabolic function. Alteration of the epigenome during fetal development might be an underlying mechanism linking prenatal androgenization and endocrine disorders in adulthood, such as the polycystic ovary syndrome (PCOS) \[[@CR33]\]. Prenatal androgenization produces features of the metabolic syndrome in rodents, including increased body weight and visceral adiposity, impaired insulin secretion, and hepatic triglyceride content \[[@CR29], [@CR30]\]. These alterations could be partly mediated by food intake, as androgenization of female rats in the neonatal period leads to a feeding pattern in adulthood that is more similar to that of male rats, including diminished meal number and increased meal size and food intake as well as increased weight \[[@CR34]\]. Female rhesus monkeys exposed to increased levels of testosterone during early-to-mid gestation develop metabolic abnormalities found in PCOS women, including insulin resistance, increased visceral fat accumulation, impaired pancreatic beta-cell function, and type 2 diabetes \[[@CR28], [@CR31], [@CR35]\]. Interestingly, the effect of prenatal androgen excess is not only restricted to females but is also present in prenatally androgenized male monkeys, who displayed by insulin resistance and impaired pancreatic beta-cell function despite no changes in adult androgen levels \[[@CR32]\].

Extrapolating findings from experimental animal studies to humans is complicated by a variety of factors that differ across species, including the markedly different placentation patterns and duration of pregnancy \[[@CR1]\]. Measuring prenatal androgen exposure in humans is inherently difficult. Amniocentesis, in which a small amount of fluid is sampled from the amniotic sac surrounding the developing fetus, provides the most informative measurement of prenatal androgen exposure. It is, however, invasive and carries a risk of miscarriage and should therefore only be performed when there is medical need \[[@CR15]\]. The comparison of twins from OS and SS pairs is considered a proxy measure of prenatal hormone exposure, as hormone transfer in twin pregnancies could occur through one of the following routes: the maternal-fetal route (through the maternal bloodstream) or the fetal-fetal route (diffusion across fetal membranes). A relatively small study did not detect differences in maternal serum steroid levels between mothers who were expecting OS or SS DZ twins, making the maternal route less plausible \[[@CR5]\]. At birth, females with a twin brother are not exposed to higher androgen concentrations compared with females with a twin sister \[[@CR36]\]. Other studies of singletons have found that maternal serum testosterone concentrations differ between women carrying male and female fetuses \[[@CR37], [@CR38]\] and that maternal and fetal testosterone are positively correlated \[[@CR39]\]. Thus, it is likely that human sex steroids are transferred between twins, but direct evidence for the hormone transfer to occur in humans does not exist.

Multiple twin studies have studied whether fetuses gestated with a male co-twin are masculinized in development, and results on perception, cognition, physiological, and morphological outcomes are more consistent with the TTT hypothesis than those on behavioral traits, including, for example, disordered eating, sensation seeking and aggression \[[@CR15]\]. Relatively few twin studies have studied whether anthropometry and health outcomes differ between OS and SS twins. Among recent studies, Ahrenfeldt et al. \[[@CR14]\] found no significant differences in hormone-dependent cancer incidence between OS and SS twins using a large sample of Nordic twins. Alexanderson et al. \[[@CR11]\] found no differences in height, while weight, BMI, and the prevalence of dyslipidemia were higher for women from OS pairs than SS pairs older than age 60 years using the Screening Across the Lifespan Twin study, which is also included in the CODATwins project as part of the Swedish twin studies. Loehlin and Martin \[[@CR9]\] reported a marginally significant increased height for females from OS compared with females from SS pairs. Gaist et al. \[[@CR40]\] found no differences in any of the strength and anthropometric measures for middle-aged female twins from the Danish population-based twin registry.

The main strengths of the present study are that it includes data from 122,302 dizygotic twin individuals from 31 twin studies in 19 countries, increasing the generalizability of the findings and reducing the type 2 error. Furthermore, the narrow confidence intervals indicate high precision. There was low to moderate heterogeneity across cohorts, suggesting relatively consistent findings across studies. Height is a classic example of a sexually dimorphic trait; on average, men are taller than women in all human populations \[[@CR41]--[@CR43]\]; thus, the large sex difference makes it worth the investigation in relation to the prenatal hormone transfer hypothesis. As the sexual dimorphism is greater for body composition and body fat distribution than for BMI \[[@CR44]\], we acknowledge the lack of more detailed adiposity measures as a limitation of this study. Zygosity was self-reported and not verified by DNA testing in the majority of studies. That almost all heights and weights were self-reported is another limitation, since perception of body weight has been reported to depend on sibling's weight and sibling's weight perceptions, and these relationships have been found to differ by the sex of the sibling \[[@CR45]\]. We further acknowledge the lack of data on pubertal timing, a key developmental period that could affect adult weight and height. A recently published study reports the height and BMI differences between OS and SS twins to depend on breastfeeding status. Never-breastfed SS twins tended to be shorter and lighter than never-breastfed OS twins, but breastfed SS twins were consistently taller and heavier than breastfed OS twins throughout adolescence and early adulthood \[[@CR46]\]. We recognize the lack of early-life nutritional data as another limitation, and more research is undoubtedly warranted in this field.

Conclusions {#Sec7}
===========

Results from this large international twin collaboration show that females with a twin brother were on average 0.31 cm taller than females with a twin sister. Males with a twin sister were also on average slightly taller than males with a twin brother, but this height difference was only 0.14 cm. Although statistically significant, the observed differences were of small magnitudes and therefore of limited public health importance. Mean BMI and the prevalence of being overweight or obese did not differ between males and females from SS and OS twin pairs. Thus, the present findings provide no evidence to support the hypothesis that in utero exposure to testosterone or postnatal socialization (i.e., having grown up with a twin of the opposite sex) has a major impact on height and BMI in later life. However, these results do not rule out the possibility that OS and SS twins differ in height or BMI at other developmental periods such as prenatal development, early infancy, or during puberty.

Additional files
================

 {#Sec8}

Additional file 1: Table S1.Sample size, mean, standard deviation and range for age by cohort in females from same- and opposite-sex dizygotic twin pairs. **Table S2.** Sample size, mean, standard deviation, and range for age by cohort in males from same- and opposite-sex dizygotic twin pairs. **Table S3.** Sample size, mean, and standard deviation for height (cm) and BMI (kg/m^2^) by cohort in females from same- and opposite-sex dizygotic twin pairs. **Table S4.** Sample size, mean, and standard deviation for height (cm) and BMI (kg/m^2^) by cohort in males from same- and opposite-sex dizygotic twin pairs. (DOCX 45 kb) Additional file 2: Figure S1.The differences in height (cm) between opposite sex (OS) and same sex (SS) plotted against the mean heights (cm) of the cohorts for females and males. The figure examines whether the difference in height between OS and SS twins is greater in taller cohorts. The Spearman correlations are *r* = −0.16 and *p* = 0.39 for females and *r* = 0.10 and *p* = 0.59 for males. **Figure S2.** The differences in BMI (kg/m^2^) between opposite-sex (OS) and same-sex (SS) twins plotted against the mean BMIs (kg/m^2^) of the cohorts for females and males. The figure examines whether the difference in BMI between OS and SS twins is greater in heavier cohorts. The Spearman correlations are *r* = −0.39 and *p* = 0.029 in females and *r* = 0.10 and *p* = 0.61 for BMI in males. (DOCX 159 kb)
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